TRMT6 was up-regulated in HCC tissues, and higher TRMT6 expression levels was correlated with reduced OS (P = 0.0224) and RFS (P = 0.0146) in patients with primary HCC (Wang et al., 2019). Here, TRMT6 is linked to hepatocellular carcinoma.